StonvexLoading…
StonvexStonvexStonvexCore line items from TROW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.86B | $7.31B | $5.38B | $3.49B |
Operating Income | $680.50M | $2.19B | $1.72B | $1.07B |
Net Income | $498.20M | $2.09B | $1.64B | $995.70M |
EPS (Diluted) | $2.23 | $9.24 | $7.25 | $4.38 |
Total Assets | $14.39B | $14.34B | $14.73B | $14.34B |
Total Liabilities | $2.52B | $2.29B | $2.76B | $2.53B |
Cash & Equivalents | $3.73B | $3.38B | $3.63B | $3.06B |
Free Cash Flow OCF − CapEx | $762.30M | $1.48B | $1.56B | $1.02B |
Shares Outstanding | 217.60M | 218.56M | 220.90M | 221.50M |